VHL 7.69% 14.0¢ virax holdings limited

Previous trials with TCN-P, page-18

  1. 366 Posts.
    No worries, was a good discussion. I still think TCN-P has promise going forward as I've said, but Legume has gathered up some great background info as well worth considering. VHL has a few things going for it rather than just TCN-P so check out Transgene's website for info on tg4001 and mainly tg4010, also look into ggti-2418 (was last with Tigris Pharmaceuticals I believe).

    All the best to holders.
 
watchlist Created with Sketch. Add VHL (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.